These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis]. Zatońska K; Bolanowski M Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962 [TBL] [Abstract][Full Text] [Related]
3. [Hormonal and biochemical parameters in postmenopausal osteoporosis]. Dourador EB; de Falco V; Chahade WH; Cossermelli W; Yoshinari NH Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):60-2. PubMed ID: 9435397 [TBL] [Abstract][Full Text] [Related]
4. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Sijanovic S; Karner I Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925 [TBL] [Abstract][Full Text] [Related]
5. [Differential osteoporosis diagnosis in the woman]. Lippuner K; Jaeger P Ther Umsch; 1998 Nov; 55(11):685-95. PubMed ID: 9865145 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis prevention and treatment: its relevance to breast cancer patients. Hodsman AB Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521 [TBL] [Abstract][Full Text] [Related]
7. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Shaarawy M; Zaki S; Sheiba M; El-Minawi AM Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333 [TBL] [Abstract][Full Text] [Related]
8. [Antiresorptive therapy for bone]. Fortschr Med Suppl; 1997; 181():1-11. PubMed ID: 9332029 [No Abstract] [Full Text] [Related]
9. [Osteoporosis and nutrition]. Burckhardt P Ther Umsch; 1998 Nov; 55(11):712-6. PubMed ID: 9865148 [TBL] [Abstract][Full Text] [Related]
10. [The management of thyrotoxicosis: a schematic approach]. Papi G; Carapezzi C; Corsello SM Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503 [TBL] [Abstract][Full Text] [Related]
11. Ghrelin and bone mass in postmenopausal hypertensive women. Pérez-Castrillón JL; Justo I; Sanz A; San Miguel A; Mazón MA; Abad L; Vega G; Dueñas A Ann Nutr Metab; 2007; 51(3):223-7. PubMed ID: 17587793 [TBL] [Abstract][Full Text] [Related]
12. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358 [TBL] [Abstract][Full Text] [Related]
13. [Bone histology in postmenopausal osteoporosis--variations in cellular activity]. Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387 [TBL] [Abstract][Full Text] [Related]
14. [Osteoporosis and nutrition]. Allolio B Z Arztl Fortbild (Jena); 1996 Feb; 90(1):19-24. PubMed ID: 8650958 [TBL] [Abstract][Full Text] [Related]